Fellow PBSA member Lawrence LaMotte stresses the importance for Congress to use their oversight and ensure the FDA publishes guidance on #biosimilars issues essential to patient safety today in The Hill.
FDA delay on biosimilars Is a safety ... - HFI Connect - Hep...
FDA delay on biosimilars Is a safety risk for patients
Written by
HFIAdmin
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Just found out I have Hep B and have red spots all over is that normal.
Hello everyone, I recently went to the doctors for food poisoning and found out I have typhiod and...
Overwhelmed
Hi everyone, I'm new to this site and really just looking for somewhere I can talk to people that...
Hepatitis E
I got infected by Hepatitis E two months ago and i am still suffering from this. My highest...
